Hodges Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-15,592
| Closed | -$16K | – | 246 |
|
|
2019
Q1 | $16K | Hold |
15,592
| – | – | ﹤0.01% | 231 |
|
|
2018
Q4 | $12K | Hold |
15,592
| – | – | ﹤0.01% | 225 |
|
|
2018
Q3 | $33K | Hold |
15,592
| – | – | ﹤0.01% | 247 |
|
|
2018
Q2 | $36K | Hold |
15,592
| – | – | ﹤0.01% | 248 |
|
|
2018
Q1 | $50K | Hold |
15,592
| – | – | ﹤0.01% | 242 |
|
|
2017
Q4 | $64K | Sell |
15,592
-10,000
| -39% | -$41K | ﹤0.01% | 243 |
|
|
2017
Q3 | $116K | Buy |
25,592
+15,592
| +156% | +$70.7K | 0.01% | 246 |
|
|
2017
Q2 | $33K | Hold |
10,000
| – | – | ﹤0.01% | 258 |
|
|
2017
Q1 | $92K | Sell |
10,000
-15,000
| -60% | -$138K | ﹤0.01% | 260 |
|
|
2016
Q4 | $193K | Sell |
25,000
-10,000
| -29% | -$77.2K | 0.01% | 266 |
|
|
2016
Q3 | $400K | Hold |
35,000
| – | – | 0.02% | 219 |
|
|
2016
Q2 | $431K | Sell |
35,000
-20,000
| -36% | -$246K | 0.02% | 203 |
|
|
2016
Q1 | $556K | Buy |
55,000
+20,000
| +57% | +$202K | 0.03% | 196 |
|
|
2015
Q4 | $789K | Hold |
35,000
| – | – | 0.03% | 183 |
|
|
2015
Q3 | $581K | Buy |
35,000
+10,000
| +40% | +$166K | 0.02% | 204 |
|
|
2015
Q2 | $562K | Buy |
25,000
+5,000
| +25% | +$112K | 0.02% | 217 |
|
|
2015
Q1 | $516K | Buy |
20,000
+5,000
| +33% | +$129K | 0.02% | 212 |
|
|
2014
Q4 | $326K | Hold |
15,000
| – | – | 0.01% | 236 |
|
|
2014
Q3 | $284K | Hold |
15,000
| – | – | 0.01% | 245 |
|
|
2014
Q2 | $349K | Hold |
15,000
| – | – | 0.02% | 214 |
|
|
2014
Q1 | $505K | Hold |
15,000
| – | – | 0.03% | 180 |
|
|
2013
Q4 | $443K | Buy |
15,000
+3,000
| +25% | +$88.6K | 0.03% | 174 |
|
|
2013
Q3 | $184K | Buy |
+12,000
| New | +$184K | 0.02% | 217 |
|